This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: University of Toronto. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Abbarna A Cumaraswamy: Innovator in STAT5 Inhibition
Introduction
Abbarna A Cumaraswamy is a notable inventor based in Etobicoke, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit specific biological pathways.
Latest Patents
Cumaraswamy holds a patent for "Sulfonamide compounds and their use as STAT5 inhibitors." This patent describes compounds that are designed to inhibit the STAT5 protein, which plays a crucial role in various cellular processes. The compounds are represented by a specific formula, indicating their potential therapeutic applications.
Career Highlights
Cumaraswamy is affiliated with the University of Toronto, where he engages in research and development activities. His work focuses on innovative solutions in the realm of biochemistry and pharmacology.
Collaborations
He collaborates with esteemed colleagues such as Patrick Thomas Gunning and Andrew Martin Lewis, contributing to a dynamic research environment that fosters innovation.
Conclusion
Abbarna A Cumaraswamy's work in developing STAT5 inhibitors showcases his commitment to advancing medical science through innovative research. His contributions are paving the way for potential breakthroughs in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile